BCAX
NASDAQ · Biotechnology
Bicara Therapeutics Inc
$27.66
+0.15 (+0.55%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
-47.6% upside
Low Target
$9.75
Average Target
$14.50
High Target
$19.19
Current Price
$27.66
Current
$27.66
$27.66
Target
$14.50
$14.50
$9.75
$14.50 avg
$19.19
Scenario Analysis
Bear Case
$9.75
-64.8%
Low target
Base Case
$14.50
-47.6%
Avg target
Bull Case
$19.19
+-30.6%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$30.99
-10.7% from high
52-Week Low
$9.57
+189.0% from low
Target vs 52W High
$14.50
-53.2% vs high
Next Earnings Report
Aug 11, 2026 · Before Market Open
2d
until earnings
EPS Est: $-0.85
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |